2024 STI Clinical Update: San Francisco Department of Public Health (SFDPH)
Thursday, March 14, 2024
Hybrid event. Please note: CME not available for viewing the recording.
Presented by:
Dr. Oliver Bacon Medical Director, San Francisco City Clinic San Francisco Department of Public Health
Dr. Franco Chevalier Deputy Medical Director, San Francisco City Clinic San Francisco Department of Public Health
Dr. Stephanie Cohen Director, HIV/STI Prevention, Disease Control Branch, San Francisco Department of Public Health
Dr. Kelly Johnson Medical Director, California Prevention Training Center Public Health Medical Officer, STD Control Branch, California Department of Public Health
Emcee: Dr. Ina Park Principal Investigator, California Prevention Training Center
Description
More than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in the U.S. in 2022, and San Francisco has higher chlamydia, gonorrhea, syphilis, and HIV rates compared to the rest of the state and nation. This half-day, hybrid event will provide important updates in the field of sexual health to help providers strengthen the delivery of STI prevention and care. Hear from local experts on STI epidemiology in San Francisco, updates on Doxy-PEP implementation, recognizing dermatologic manifestations of STIs, and a lively case panel.
Learning Objectives
Summarize current STI trends in San Francisco
Be familiar with updates to STI treatment guidelines and innovations in STI prevention and diagnostics
Understand how to implement Doxy-PEP for STI prevention
Recognize common dermatologic manifestations of STIs
STI Clinical Update Webinar – Introduction to Syphilis and Congenital Syphilis: A Phoenix IHS and CAPTC Event
January 11, 2024
8:30AM-12:00PM (MST)
Presented by CAPTC Clinical Faculty
Please note: CME not available for viewing the webinar recording.
Presenters:
Sharon Adler, MD, MPH, Clinical Faculty, California Prevention Training Center
Wyatt Hanft, MD, MPH, AAHIVS, STI Fellow, California Prevention Training Center
Tamara Ooms, RN, MSN, FNP, Program Manager, California Prevention Training Center
Ina Park, MD, MS, Principal Investigator, California Prevention Training Center
Rosalyn Plotzker, MD, MPH, Clinical Faculty, California Prevention Training Center
Moderator: Kelly Johnson, MD, MPH, Medical Director, California Prevention Training Center
Learning Objectives:
Describe the varied clinical manifestations of syphilis in adults & congenital syphilis (CS) in infants
Recognize that there are two different screening algorithms used to diagnose syphilis in adults
Define adequate treatment for syphilis, including during pregnancy
List at least 3 strategies to prevent syphilis in adults and infants
STI Expert Hour Webinar – Navigating the Bicillin L-A Shortage: A Conversation with PharmD Dr. Kathy Yang
January 31, 2024
12:00PM-1:15PM (PST)
1.25 CME units at no cost
Please note: No CME available for viewing the webinar recording.
Learning Objectives
List at least 2 factors contributing to ongoing Bicillin L-A shortages
Describe a framework for prioritizing Bicillin L-A when supplies are limited
Name potential alternative treatments for syphilis in non-pregnant people
Develop a decision-making process for the treatment of syphilis when standard guidelines cannot be followed or when data is insufficient.
Meet Our Expert: Kathy Yang, PharmD, MPH
Dr. Yang is a Health Sciences Clinical Professor in the Department of Clinical Pharmacy and the Co-Vice Dean of Clinical Innovation and Entrepreneurship at the University of California, San Francisco School of Pharmacy. She is also an Infectious Diseases Clinical Pharmacist in the UCSF Medical Center. Dr. Yang specializes in pharmacokinetic and pharmacodynamic optimization of the treatment of multi-drug resistant infections, particularly gram-negative bacteria such as Pseudomonas aeruginosa. For the past 3 years, Dr. Yang has focused her efforts on the clinical management of COVID-19.
Congenital Syphilis Hotline Pilot
California Clinicians:
Do you have an URGENT congenital syphilis case and need SAME DAY expert consultation?
January 1 – March 31, 2024
www.stdccn.org
2023 Hawai’i STI Clinical Update
October 17, 2023
9AM-5PM (HST)
Honolulu, HI / Virtual
1-day in-person and virtual training covering the following topics:
Syphilis in Pregnancy
Congenital Syphilis
Gonorrhea (GC)/Chlamydia (CT), including extragenital testing
Dermatologic manifestations of STIs – Urethritis/Vaginitis (including syndromic management)
Sexual assault and STIs
Presented by:
Kelly Johnson, MD,MPH, Medical Director, California Prevention Training Center
Tamara Ooms, RN, MSN, FNP, Program Manager, California Prevention Training Center
Rosalyn Plotzker, MD, MPH, Clinical Faculty, California Prevention Training Center
Alan Katz, MD, MPH, Staff Physician, Hawai’i State Department of Health
Moderator: Breena Gaskov, BS, Outreach Epidemiological Specialist, Hawai’i State Department of Health
Learning Objectives
Explain prenatal syphilis screening and treatment recommendations
Describe the clinical and public health approaches to GC/CT prevention
Summarize data from recent studies exploring the use of doxy PEP to prevent bacterial STIs
Compare potential strategies for doxy-PEP implementation in clinical settings
Recognize dermatologic signs of sexually transmitted infections (STIs)
Delineate treatment approaches for syndromes suggestive of STIs
STI Clinical Update Humboldt County-Addressing the Rise of Syphilis: A Review of Clinical Management of Syphilis and Congenital Syphilis for Health Care Providers
Presented by Drs. Kathleen Jacobson and Wyatt Hanft
Describe the stages of syphilis and the recommended treatment and follow up for people with syphilis
Compare the traditional and reverse algorithm for syphilis screening
Please note: CME not offered for viewing the recording of the update
How to Prescribe Expedited Partner Therapy (EPT) for Sexually Transmitted Infections
Expedited Partner Therapy (EPT) is the clinical practice of treating sex partners of patients diagnosed with certain sexually transmitted infections (STIs) – including chlamydia (CT), gonorrhea (GC), and trichomoniasis – without the health care provider first examining the partner(s). EPT usually involves patient delivered partner therapy (PDPT), in which the patient delivers the medication or a prescription to their partner(s). While evaluating the partner and providing other needed health services would be ideal, this is often not feasible. EPT can be provided confidentially; it is effective, safe, acceptable to patients and partners, and helps to ensure timely partner treatment.
This resource contains information on how to prescribe EPT in California, including sample prescriptions, information on billing/reimbursement, and patient-facing materials.
This page houses PrEP Learning Collaborative videos and slides from 03/2022 to 09/2024. Sessions occurring after 09/2024 will be entered individually as resources.
Examination and Interpretation of Wet Preparations of Vaginal Specimens
In-person laboratory course onsite at the UC San Francisco campus
Intended for practicing clinicians with prior wet mount experience and microscopy skills
Capacity limited to 8 persons
The course begins with a fifteen minute didactic presentation on applicable issues of CLIA regulation, quality control, and interpretation vaginal wet mount (VWM) for common causes of vaginitis. This will be followed by a fifteen minute video that details through the microscope footage of findings on VWM including trichomads, yeast and clue cells associated with BV. The remaining two and one-half hours consists of experiential training, including laboratory practicum on examination of saline and KOH vaginal wet mounts (VWM). During this portion of the training, participants will have an opportunity for group discussion, explanation, and demonstration, as well as practice and return demonstration.
Learning Objectives
Practice proper preparation of saline and KOH specimens of vaginal fluid to increase viability of specimens for microscopic evaluation.
Perform proper use of the light microscope to improve examination of saline and KOH wet mount specimens.
Assess wet mount microscopy specimens to appropriately interpret findings that support diagnosis of vulvovaginal candidiasis, bacterial vaginosis or trichomoniaisis.
STI Clinical Update Webinar: California Mpox Update for Healthcare Providers – October 2023
Thursday, October 26, 2023 12:00 PM – 1:30 PM (PDT)
The California Department of Public Health (CDPH) continues to see statewide Mpox activity, including a large cluster in Los Angeles County. This webinar, presented by the California Prevention Training Center (CAPTC), features CDPH’s Mpox Clinical and Epidemiology teams, who will provide a clinical update and epidemiological overview of Mpox, and discuss new research findings relevant to primary care and other healthcare providers, including data on transmission, vaccine equity, and vaccine effectiveness. A question-and-answer session will follow.
Presented by:
Kayla Saadeh, MPH Mpox Epidemiology Unit Lead California Department of Public Health
Jessica Watson, MD, MPH Mpox Public Health Medical Officer and Acting Clinical Lead California Department of Public Health
Learning Objectives
Identify the clinical and epidemiological factors leading to Mpox infection, transmission, and severity as well as treatment options.
Apply the latest information and research on Mpox, including transmission characteristics, vaccine equity, and vaccine effectiveness, to your clinical practice to ensure patients are appropriately vaccinated, diagnosed, tested, and treated for Mpox.
Please note: CME not available for viewing the webinar recording.
Before You Watch
By clicking this box, you agree to use these videos for training and educational purposes only. Do not copy, download, share, or distribute the content. These materials may not be uploaded or used in artificial intelligence or machine learning systems.
We use cookies to ensure that we give you the best experience on our website, but we also recognize the right to privacy. Please accept or disable cookies for this website.
